Invention Grant
- Patent Title: Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A
-
Application No.: US15565933Application Date: 2016-04-12
-
Publication No.: US10851176B2Publication Date: 2020-12-01
- Inventor: Marie-Christine Bouton , Petrus Lenting , Cécile Denis , Olivier Christophe
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) , UNIVERSITÉ PARIS DIDEROT—PARIS 7 , UNIVERSITÉ PARIS XIII PARIS-NORD
- Applicant Address: FR Paris FR Paris FR Villetaneuse
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE PARIS DIDEROT—PARIS 7,UNIVERSITE PARIS XIII PARIS-NORD
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE PARIS DIDEROT—PARIS 7,UNIVERSITE PARIS XIII PARIS-NORD
- Current Assignee Address: FR Paris FR Paris FR Villetaneuse
- Agency: W&C IP
- Priority: EP15305544 20150413
- International Application: PCT/EP2016/058034 WO 20160412
- International Announcement: WO2016/166110 WO 20161020
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/38 ; A61K39/00
Abstract:
The present invention relates to a method and compositions for the treatment of haemorrhagic diseases.
Public/Granted literature
- US20180105603A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HAEMORRHAGIC DISEASES Public/Granted day:2018-04-19
Information query
